| Recruiting | Observational Study of Gut Microbiota in Abemaciclib-Treated Patients With and Without Diarrhea Breast Neoplasms, Hormone Receptor-Positive Breast Cancer, Abemaciclib | — | 2025-12-21 |
| Recruiting | DIEP Flap Breast Reconstruction: Perioperative Biomarkers and Outcomes Breast Neoplasms, Ischemia-Reperfusion Injury, Postoperative Complications | — | 2025-12-20 |
| Not Yet Recruiting | Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib Breast Cancer, Drug-Related Side Effects, Diarrhea | — | 2025-12-01 |
| Not Yet Recruiting | A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benig Breast Cancer, Nipple Discharge | — | 2025-12-01 |
| Not Yet Recruiting | Study on the Relationship Between Opioid Drugs and the Therapeutic Efficacy of Immunotherapy Pain Management, Immune Checkpoint Inhibitor, Opioid | — | 2025-09-17 |
| Recruiting | SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) Breast Cancer | Phase 2 | 2024-11-28 |
| Recruiting | SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer Breast Cancer | Phase 2 | 2024-11-28 |
| Recruiting | Effect of Different Surgical Approaches of Granulomatous Mastitis Breast-conserving Plastic Surgery, Granulomatous Mastitis | N/A | 2024-11-01 |
| Enrolling By Invitation | CNCMT：a Multi-center, Prospective, Single-arm Study Locally Advanced Cervical Cancer, PD1, CTLA4 | N/A | 2024-10-08 |
| Recruiting | Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemot Advanced Non-Small Cell Squamous Lung Cancer, Radiotherapy, Immunotherapy | N/A | 2024-03-13 |
| Recruiting | Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy Non Small Cell Lung Cancer, Locally Advanced, Radiotherapy | N/A | 2024-02-08 |
| Recruiting | Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients Elderly Patients, Metastatic Lung Cancer | Phase 2 | 2024-02-01 |
| Recruiting | Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With Nausea With Vomiting Chemotherapy-Induced | N/A | 2023-12-01 |
| Enrolling By Invitation | Investigating the Effects of Different Incision Types on Aesthetic Outcomes and Incision-related Complications Breast Neoplasm Female | — | 2023-07-18 |
| Recruiting | Neoadjuvant Radiotherapy and Immediate Implant-Based Breast Reconstruction Breast Cancer, Implant Breast Reconstruction, Neoadjuvant Radiotherapy | N/A | 2023-07-08 |
| Active Not Recruiting | Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Thei Nasopharyngeal Carcinoma (NPC) | — | 2023-04-01 |
| Unknown | Pifenidone Prophylactic Therapy for Radiation Lung Injury in Patients Who Have Previously Received Immune Chec Lung Cancer | Phase 2 | 2023-03-31 |
| Unknown | The Risk Factors for Acute Radiation Pneumonitis in Patients With Prior Receipt of Immune Checkpoint Inhibitor Cancer Patients | — | 2022-06-01 |
| Unknown | Surufatinib With or Wothout Immunotherapy for Advanced Colorectal Cancer in Later Line Colorectal Neoplasms | Phase 2 | 2022-03-30 |
| Unknown | Impact of Baduanjin Qigong Exercise on Fatigue in Patients With NSCLC Undergoing Adjuvant Chemotherapy Fatigue | N/A | 2021-12-01 |
| Completed | Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negati NSCLC | Phase 1 | 2021-10-01 |
| Unknown | Selected De-escalation Radiotherapy for Postoperative Head and Neck Squamous Cell Carcinoma Head and Neck Squamous Cell Carcinoma, Radiotherapy, Immunotherapy | Phase 2 | 2021-01-01 |
| Unknown | Apatinib Combined With Radiotherapy in Patient With BM From Drive Gene Negative NSCLC NSCLC | Phase 2 | 2020-09-10 |
| Completed | Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin Nasopharyngeal Carcinoma | Phase 2 | 2015-08-01 |